PDG21 THE GENERIC ENTRY AND MARKET SHARE COMPETITION OF STATINS MEDICATION USE: A RETROSPECTIVE TREND ANALYSIS OF UTILIZATION, SPENDING, AND PRICES IN THE UNITED STATES MEDICAID PROGRAMS FROM 1991 TO 2017

May 1, 2020, 00:00
10.1016/j.jval.2020.04.311
https://www.valueinhealthjournal.com/article/S1098-3015(20)30499-X/fulltext
Title : PDG21 THE GENERIC ENTRY AND MARKET SHARE COMPETITION OF STATINS MEDICATION USE: A RETROSPECTIVE TREND ANALYSIS OF UTILIZATION, SPENDING, AND PRICES IN THE UNITED STATES MEDICAID PROGRAMS FROM 1991 TO 2017
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30499-X&doi=10.1016/j.jval.2020.04.311
First page :
Section Title :
Open access? : No
Section Order : 10178
Categories :
Tags :
Regions :
ViH Article Tags :